Thus, although neuroblastoma cells are more sensitive to TH34 than cell lines of other tumor entities, even neuroblastoma cells show diverse responses, possibly related to different MYCN expression levels (amplification versus single copy). This evidence concerns the gene MYCN and neoplasm.